Erik Nygren

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant

Jan Holmgren, Louis Bourgeois, Nils Carlin et al. · Vaccine · 2013 · 132 citations

Th17 development and autoimmune arthritis in the absence of reactive oxygen species

Annie George‐Chandy, Inger Nordström, Erik Nygren et al. · European Journal of Immunology · 2008 · 68 citations

Th17 Development, Immunology, Pathology +17

A Proinflammatory Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Affects Neutrophil, Monocyte, and NK Cell Functions

Lars Bellner, Fredrik B. Thorén, Erik Nygren et al. · The Journal of Immunology · 2005 · 66 citations

Establishment of an Adult Mouse Model for Direct Evaluation of the Efficacy of Vaccines against <i>Vibrio cholerae</i>

Erik Nygren, B.-L. Li, Jan Holmgren et al. · Infection and Immunity · 2009 · 54 citations · Full text

Alkaline pH Is a Signal for Optimal Production and Secretion of the Heat Labile Toxin, LT in Enterotoxigenic Escherichia Coli (ETEC)

Lucia Gonzales‐Siles, Zahra Bagher Ali, Erik Nygren et al. · PLoS ONE · 2013 · 46 citations · Full text

Microbial Toxin, Enterotoxigenic Escherichia Coli, Biochemistry +13